Objectives: Linezolid-resistant opportunistic human pathogens Enterococcus faecalis and Enterococcus faecium are emerging health threats as limited therapeutic options remain. The aim of this study was to investigate the epidemiology, resistance mechanisms, and genetic diversity of linezolid-resistant enterococci (LRE) isolated between 2013 and 2021 and received at the Belgian National Reference Centre (NRC) for Enterococci.
Methods: Linezolid susceptibility testing was performed upon request on 2458 submitted enterococci strains.
Background: Colistin serves as the last line of defense against multidrug resistant Gram-negative bacterial infections in both human and veterinary medicine. This study aimed to investigate the occurrence and spread of colistin-resistant Enterobacterales (ColR-E) using a One Health approach in Belgium and in the Netherlands.
Methods: In a transnational research project, a total of 998 hospitalized patients, 1430 long-term care facility (LTCF) residents, 947 children attending day care centres, 1597 pigs and 1691 broilers were sampled for the presence of ColR-E in 2017 and 2018, followed by a second round twelve months later for hospitalized patients and animals.
Ann Intensive Care
January 2024
Background: Recent alerts have highlighted an increase in group A streptococcal (GAS) infections since 2022 in Europe and the United States. Streptococcus pyogenes can cause limited skin or mucosal disease, but can also present as severe invasive disease necessitating critical care. We performed a multicenter retrospective study of patients with GAS infections recently admitted to Belgian intensive care units (ICUs) since January 2022.
View Article and Find Full Text PDFMany European countries have recently reported upsurges in invasive group A (iGAS) infections, mainly caused by 1 , specifically the toxigenic M1 lineage. We present the epidemiology of 1 causing iGAS in Belgium during 2018-August 2023, and describe an emergence of the toxigenic M1 lineage in Belgium in mid-2022 that was observed as an increase in bloodstream infections caused by 1 that continued into 2023.
View Article and Find Full Text PDF